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Congenital infection with human cytomegalovirus
(HCMV) is most common intrauterine acquired virus
infection in infants in the developed world. Rates of con-
genital HCMV infection range from 0.2%-2.0% in live
births. Although maternal infection with this virus rarely
results in clinical symptoms, approximately 10% infants
born with congenital HCMV infection can exhibit symp-
tomatology ranging from mild hepatitis to severe multior-
gan dysfunction, including damaging central nervous
system infection. CNS infection can result in microceph-
aly, retinitis, and abnormalities in psychomotor function.
More commonly, infants are clinically asymptomatic at
birth but between 10-20% of infected infants will exhibit
long term deficits in neurological function, with hearing
loss being the most common long-term sequelae. Con-
genital HCMV infection is thought to be the most com-
mon non-familial cause of hearing loss. Although these
characteristics of congenital HCMV infection are well
described in studies from the developed world, little is
known about the natural history of this infection in
resource constrained countries. However, several studies
have demonstrated that the incidence of congenital
HCMV infection increases with increasing maternal infec-
tion. Recent findings from Brazil and India are consistent
with these earlier studies and indicate that congenital
HCMV infection occurs in 1-2% of newborn infants in
most of the world's populations. Because HCMV infection
is universal in these maternal populations and infection is
acquired early in life, these findings indicate that maternal
immunity to this virus is insufficient to prevent infection
and perhaps can only modulate the incidence of disease
in infected infants. Studies from the US have demon-
strated that infected infants born to women with precon-
ceptional immunity exhibit rates of developmental
abnormalities similar to those infants born to women
with primary infection acquired during pregnancy. The
mechanisms that account for the inability of maternal
immunity to prevent infection and limit disease in the
developing fetus infected with HCMV have not been
defined, but reinfection with new strains of virus has been
shown to occur in normal host following community
exposure. Reinfection of previously infected hosts with
new strains of virus is common in animal models and
recent studies in normal women suggest that rates of rein-
fection could exceed 20% per annum. HCMV has been
shown to encode a number of viral functions that can
evade both innate and adaptive immunity in-vitro and in
experimental animal models. Although antiviral antibod-
ies have been shown to neutralize virus in-vitro, strain
dependent virus neutralizing antibody responses have
been well described and appear to arise from minor
sequence variation (1-3%) in some envelop glycoproteins
such as gB whereas significant variations of > 25% have
been reported in other envelop glycoproteins (gN).
Whether these differences account for reinfection with dif-
ferent strains of HCMV and contribute to disease in con-
genitally infected infants remains to be determined.
However, the apparent contribution of reinfection to the
natural history of this congenital infection in the develop-
ing world suggests that HCMV could be a significant cause
of morbidity in infants in resource-constrained countries
as well as in the developed world.
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